393 related articles for article (PubMed ID: 24215737)
1. Development of transdermal therapeutic formulation of CNS5161, a novel NMDA receptor antagonist, by utilizing pressure-sensitive adhesives II: improved transdermal absorption and evaluation of efficacy and safety.
Naruse M; Ogawara K; Kimura T; Konishi R; Higaki K
Eur J Pharm Sci; 2014 Feb; 52():86-94. PubMed ID: 24215737
[TBL] [Abstract][Full Text] [Related]
2. Development of transdermal therapeutic formulation of CNS5161, a novel N-methyl-D-aspartate receptor antagonist, by utilizing pressure-sensitive adhesives I.
Naruse M; Ogawara K; Kimura T; Konishi R; Higaki K
Biol Pharm Bull; 2012; 35(3):321-8. PubMed ID: 22382317
[TBL] [Abstract][Full Text] [Related]
3. Effects of pressure sensitive adhesives and chemical permeation enhancers on the permeability of fentanyl through excised rat skin.
Mehdizadeh A; Ghahremani MH; Rouini MR; Toliyat T
Acta Pharm; 2006 Jun; 56(2):219-29. PubMed ID: 16613727
[TBL] [Abstract][Full Text] [Related]
4. Controlled transdermal delivery of fentanyl: characterizations of pressure-sensitive adhesives for matrix patch design.
Roy SD; Gutierrez M; Flynn GL; Cleary GW
J Pharm Sci; 1996 May; 85(5):491-5. PubMed ID: 8742940
[TBL] [Abstract][Full Text] [Related]
5. Silicone adhesive, a better matrix for tolterodine patches-a research based on in vitro/in vivo studies.
Liu J; Wang Z; Liu C; Xi H; Li C; Chen Y; Sun L; Mu L; Fang L
Drug Dev Ind Pharm; 2012 Aug; 38(8):1008-14. PubMed ID: 22126709
[TBL] [Abstract][Full Text] [Related]
6. In vivo enhancement of transdermal absorption of ketotifen by supersaturation generated by amorphous form of the drug.
Inoue K; Sugibayashi K
Eur J Pharm Sci; 2012 Aug; 47(1):228-34. PubMed ID: 22728431
[TBL] [Abstract][Full Text] [Related]
7. Permeation enhancers compatible with transdermal drug delivery systems. Part I: selection and formulation considerations.
Pfister WR; Hsieh DS
Med Device Technol; 1990; 1(5):48-55. PubMed ID: 10171148
[TBL] [Abstract][Full Text] [Related]
8. Formulation optimization of a drug in adhesive transdermal analgesic patch.
Ravula R; Herwadkar AK; Abla MJ; Little J; Banga AK
Drug Dev Ind Pharm; 2016; 42(6):862-70. PubMed ID: 26288995
[TBL] [Abstract][Full Text] [Related]
9. Permeation enhancers compatible with transdermal drug delivery systems: part II: system design considerations.
Pfister WR; Hsieh DS
Med Device Technol; 1990; 1(6):28-33. PubMed ID: 10171149
[TBL] [Abstract][Full Text] [Related]
10. Design and in vivo evaluation of an indapamide transdermal patch.
Ren C; Fang L; Ling L; Wang Q; Liu S; Zhao L; He Z
Int J Pharm; 2009 Mar; 370(1-2):129-35. PubMed ID: 19114099
[TBL] [Abstract][Full Text] [Related]
11. Formulation study of a patch containing propranolol by design of experiments.
Cilurzo F; Minghetti P; Gennari CG; Casiraghi A; Selmin F; Montanari L
Drug Dev Ind Pharm; 2014 Jan; 40(1):17-22. PubMed ID: 23301830
[TBL] [Abstract][Full Text] [Related]
12. Development of a drug-in-adhesive patch combining ion pair and chemical enhancer strategy for transdermal delivery of zaltoprofen: pharmacokinetic, pharmacodynamic and in vitro/in vivo correlation evaluation.
Cui H; Quan P; Zhou Z; Fang L
Drug Deliv; 2016 Nov; 23(9):3461-3470. PubMed ID: 27257038
[TBL] [Abstract][Full Text] [Related]
13. Transdermal delivery of alprazolam from a monolithic patch: formulation based on in vitro characterization.
Soler LI; Boix A; Lauroba J; Colom H; Domenech J
Drug Dev Ind Pharm; 2012 Oct; 38(10):1171-8. PubMed ID: 22204649
[TBL] [Abstract][Full Text] [Related]
14. Formulation and biopharmaceutical evaluation of a transdermal patch containing letrozole.
Li L; Fang L; Xu X; Liu Y; Sun Y; He Z
Biopharm Drug Dispos; 2010 Mar; 31(2-3):138-49. PubMed ID: 20140970
[TBL] [Abstract][Full Text] [Related]
15. Development and in vitro evaluation of pressure sensitive adhesive patch for the transdermal delivery of galantamine: Effect of penetration enhancers and crystallization inhibition.
Ameen D; Michniak-Kohn B
Eur J Pharm Biopharm; 2019 Jun; 139():262-271. PubMed ID: 30981946
[TBL] [Abstract][Full Text] [Related]
16. Drug in adhesive patch of palonosetron: Effect of pressure sensitive adhesive on drug skin permeation and in vitro-in vivo correlation.
Liu C; Hui M; Quan P; Fang L
Int J Pharm; 2016 Sep; 511(2):1088-97. PubMed ID: 27521703
[TBL] [Abstract][Full Text] [Related]
17. Influence of formulation variables in transdermal drug delivery system containing zolmitriptan.
Subedi RK; Ryoo JP; Moon C; Choi HK
Int J Pharm; 2011 Oct; 419(1-2):209-14. PubMed ID: 21843607
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the transdermal permeation behavior of Proterguride from drug in adhesive matrix patches through hairless mouse skin.
Schurad B; Tack J; Lipp R
Drug Dev Ind Pharm; 2005 Jul; 31(6):505-13. PubMed ID: 16109623
[TBL] [Abstract][Full Text] [Related]
19. Investigation of molecular mobility of pressure-sensitive-adhesive in oxybutynin patch in vitro and in vivo: Effect of sorbitan monooleate on drug release and patch mechanical property.
Wang W; Liu C; Luo Z; Wan X; Fang L
Eur J Pharm Sci; 2018 Sep; 122():116-124. PubMed ID: 29928984
[TBL] [Abstract][Full Text] [Related]
20. Investigation on the effect of deep eutectic formation on drug-polymer miscibility and skin permeability of rotigotine drug-in-adhesive patch.
Liu C; Qu X; Song L; Shang R; Wan X; Fang L
Int J Pharm; 2020 Jan; 574():118852. PubMed ID: 31759103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
